Fingerprint
Dive into the research topics of 'Ribociclib as first-line therapy for HR-positive, advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
G. N. Hortobagyi, S. M. Stemmer, H. A. Burris, Y. S. Yap, G. S. Sonke, S. Paluch-Shimon, M. Campone, K. L. Blackwell, F. Andre, E. P. Winer, W. Janni, S. Verma, P. Conte, C. L. Arteaga, D. A. Cameron, K. Petrakova, L. L. Hart, C. Villanueva, A. Chan, E. Jakobsen
Research output: Contribution to journal › Article › peer-review